Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Agfa HealthCare

At Agfa HealthCare, we are transforming the delivery of care – supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. Focused on our robust and unified Enterprise Imaging Platform we help our clients manage resource allocation, improve productivity and provide clinical confidence with patient-centric contextual intelligence. The technology speeds diagnoses to drive an improved patient experience. With our core commitment on delivering value, the technology suits multi-specialty requirements and securely standardizes workflows, to collaborate seamlessly between departments and across geographies. From product development to implementation, our best-of-suite Imaging IT software solutions are purpose-built to reduce complexity and support healthcare providers to achieve their clinical, operational and business strategies. With a proven track record as innovators, in-depth medical knowledge and strategic guidance, we enable clients to form the foundation for an effective health IT ecosystem. Agfa HealthCare is a division of the Agfa-Gevaert Group which is headquartered in Mortsel, Belgium and traded on Euronext Brussels (AGFB).

Aidence B.V.

Aidence was founded in 2015 by Mark-Jan Harte (CEO) and Jeroen van Duffelen (CBO). Based in the Netherlands and the UK, Aidence rallies over 60 data scientists, software engineers, medical, regulatory, and business professionals to provide intelligent software for the oncology pathway. Aidence is part of the AI division of RadNet, a US-based leading provider of diagnostic imaging services. Aidence's first clinical application is Veye Lung Nodules, an AI-based solution for pulmonary nodule management on chest CTs. It automatically detects, measures, classifies, and tracks the growth of pulmonary nodules, then delivers its analysis directly into the radiology workflow. The solution is currently running in routine practice and lung cancer screening programmes across Europe, analysing thousands of patient scans each week. Aidence is the preferred AI vendor for the NHS England Targeted Lung Health Checks. Most sites involved in the programme use Aidence's solutions to manage and report pulmonary nodules. Aidence is also running a clinical study into the impact of Veye Lung Nodules on radiology decision making in routine practice. The programme, called INPACT, is a collaboration with the University of Edinburgh and Hardian Health, with funding from an AI in Health and Care Award.

Aidoc

Aidoc is the leading provider of artificial intelligence solutions that support and enhance the impact of physician diagnostic power - helping them expedite patient treatment and improve quality of care. Aidoc's solutions analyze medical images directly after the patient is scanned, notifying and activating physicians within the imaging workflow. Aidoc is committed to improving efficiency and patient outcomes, with a broad impact on key metrics such as turnaround time and length of stay. Aidoc offers the broadest AI suite on the market consisting of algorithms for the flagging and prioritization of time-sensitive pathologies and care coordination tools for multidisciplinary teams. The company has 7 FDA cleared/10 CE-marked solutions and additional acute pathologies available under clinical investigation. Aidoc's solutions are being used in over 600 medical facilities worldwide and have provided value to millions of patient scans to date.

AIMed

AMG Medtech Ltd

AMG Medtech offer a specialist consultancy service and distribution of medical technologies and AI software across the UK, Ireland and BeNeLux. Our team of people bring over 20 years experience and expertise in medical imaging, cardiology and radiotherapy. We understand the workflows and scaling them for different departments and across geographical networks, so that you can deliver quality treatment with efficiency and consistency. We understand the challenges hospitals and cancer clinics face every day with limited resources, lack of trained staff, and overwhelming clinician workloads all inadvertently take a toll on patient care and treatment. AMG Medtech are the UK & Ireland distributor for Arterys Inc and they offer a full range of AI clinical applications for Cardiac, Lung, Chest MSK, Neuro and Breast to transform healthcare by reducing subjectivity and variability in clinical diagnosis , with multiple models in one app and one User Interface for an unlimited number of features. The Arterys mission is to transform healthcare by reducing subjectivity and variability, by empowering Physicians with every piece of information they need to make the best possible diagnosis and treatment decisions. Our dream is to bring data-driven medicine to every patient, regardless of where they live, as long as you have access to the web, you have access to Arterys.

annalise.ai

annalise.ai fuses the highest quality imaging data with the very best in computer science to produce comprehensive AI clinical decision support solutions. The company’s first solution is the world’s most comprehensive AI clinical decision support chest X-ray solution on the market. Assisting clinicians to interpret radiological imaging studies, Annalise Enterprise CXR detects 124 findings, empowering clinicians to make accurate, faster decisions. Our patient-first approach is proudly clinician-led and comes from a deep understanding of the challenges faced in medical imaging. AI provides clinicians with a second set of eyes, allowing them to detect with confidence and drive better health outcomes for all patients. https://annalise.ai/

AZmed

AZmed is a French company founded in 2018 with the aim of improving doctors' working conditions and patient care. The first solution developed, Rayvolve, is a computer-aided diagnosis tool able to detect all types of fractures on standard x-rays. It allows radiologists and emergency physicians to save time and reduce the risk of diagnostic errors.

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

Contextflow

contextflow empowers radiologists to complete their daily workload faster and with higher quality and cost-efficiency by delivering unique tools that integrate directly into clinical routine. Our core technology includes SEARCH, a clinical decision support system that searches for 19 disease patterns in lung CTs plus lung nodules, providing relevant statistics, reference cases and differential diagnosis information at the point of care within seconds. contextflow is a spin-off of the Medical University of Vienna (MUW) and European research project KHRESMOI, supported by the Technical University of Vienna (TU). Founded by a team of four AI and engineering experts in July 2016, we now boast a team of over 30 team members from 17 different countries speaking just as many languages. Our international advisory board includes current and former presidents of the International and European Societies of Radiology. contextflow: See beyond a single case.

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

GLEAMER

GLEAMER develops a suite of AI solutions for Radiology that encapsulate medical-grade expertise. The company wants to support imaging users to secure diagnoses for all patients at all times while improving efficiency. GLEAMER’s AI Companions are directly integrated into the users’ usual reading environment and act as an automated and transparent second reading to improve diagnostic accuracy in X-ray imaging. GLEAMER’s solutions are currently being used across 13 countries in more than 300 institutions.

Lunit

Lunit is a medical AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers through cutting-edge deep learning technology. Founded in 2013, Lunit is one of the first-generation medical AI startups. As one of the core players of this new-rising industry, Lunit has been internationally acknowledged for its advanced, state-of-the-art AI technology and its application in medical images. It has been named by CB Insights as one of “AI 100” startups transforming the healthcare industry. Lunit’s mission is to provide AI solutions that open a new era of data-driven precision medicine. We aim to solve the most critical issues in cancer care today: reduce medical costs and prolong survival.

Medica

Milvue

Founded in 2018, Milvue is a French based company that has successfully brought state-of-the-art deep learning algorithms into the daily radiological workflow. Created by radiologists, Milvue Suite provides reliable and transparent predictive analysis on your whole x-ray workflow, along with intelligent workflow prioritization, to secure patient diagnosis while optimizing productivity. SmartUrgences® and SmartXpert® are the 2 products from Milvue Suite: SmartUrgences® - the most advanced triage and diagnostic support solution for adults and pediatrics X-rays on the market. Thanks to 7 MSK and Chest pathologies combined in one single solution, it helps prioritize any emergency x-ray workflow: ● Fracture ● Dislocation ● Join Effusion ● Pulmonary Opacity ● Pulmonary Nodule ● Pleural Effusion ● Pneumothorax Real-time visualization of detected anomalies reduces reading times while securing diagnosis. SmartXpert® - the productivity booster through a large panel of automatic useful x-ray measurements: ● Gonometry ● Pelvic tilt ● Hip Dysplasia ● Foot measurements including hallux-valgus, Djian-Annonier Angle, and many more ● CSA angle ● Cobb’s angle Milvue Suite interoperates with every PACS on the market. If you want to know more about the advantage of our fully integrated solutions, and enjoy a live demo please email us at BIR2022@milvue.com or contact paul@milvue.com +33609254551

Oxipit

Since 2017 at Oxipit we create AI solutions for global medical imaging. We aim to bring the latest technology developments to improve patient care. Oxipit story includes many ‘firsts’ - from the first fully autonomous Artificial Intelligence solution for radiological reporting to a completely new method of improving diagnostic quality. From Colombia to Australia, we help medical organizations to increase diagnostic accuracy and boost productivity, focusing on improving patient outcomes around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Qure.ai

Qure.ai is a breakthrough Artificial Intelligence (AI) solution provider that is disrupting the radiology 'status quo' by enhancing imaging accuracy and improving health outcomes with the assistance of machine learning supported tools. Qure.ai taps deep learning technology to provide automated interpretation of radiology exams like X-rays, CTs and MRI scans for time and resource-strapped medical imaging professionals—enabling faster diagnosis and speed to treatment. Qure.ai is helping to make healthcare more accessible and affordable to patients worldwide.

Siemens Healthineers

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. Further information is available at www.siemens-healthineers.co.uk

Telemedicine Clinic

TMC is Europe’s largest provider of teleradiology services by utilising qualified, sub specialist and GMC registered radiologists from Europe. Due to TMC’s investment in both IT and medical innovation, Artificial intelligence now plays a huge part in providing quality health care for all NHS patients.